Literature DB >> 9287342

Identification of a 190-kDa vascular endothelial growth factor 165 cell surface binding protein on a human glioma cell line.

T Omura1, K Miyazawa, A Ostman, C H Heldin.   

Abstract

Vascular endothelial growth factor (VEGF) is an angiogenesis factor for which two signaling protein tyrosine kinase receptors, Flt1 and KDR, have been identified. We describe here a 190-kDa component present on a human glioma cell line that binds VEGF165 with high affinity. In contrast, VEGF121 is bound only with low affinity, suggesting that the C-terminal part of VEGF165 is important for interaction with the 190-kDa component. No internalization or stimulation of tyrosine phosphorylation was recorded after ligand binding to the 190-kDa component, suggesting that it may not be directly involved in signaling; its function may be to present ligand or stabilize ligand binding to signaling receptors.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9287342     DOI: 10.1074/jbc.272.37.23317

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  3 in total

1.  Selective induction of neuropilin-1 by vascular endothelial growth factor (VEGF): a mechanism contributing to VEGF-induced angiogenesis.

Authors:  Hideyasu Oh; Hitoshi Takagi; Atsushi Otani; Shinji Koyama; Seiji Kemmochi; Akiyoshi Uemura; Yoshihito Honda
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-26       Impact factor: 11.205

2.  Oligonucleotide NX1838 inhibits VEGF165-mediated cellular responses in vitro.

Authors:  C Bell; E Lynam; D J Landfair; N Janjic; M E Wiles
Journal:  In Vitro Cell Dev Biol Anim       Date:  1999-10       Impact factor: 2.416

3.  CRAdRGDflt-IL24 virotherapy in combination with chemotherapy of experimental glioma.

Authors:  L N Kaliberova; V Krendelchtchikova; D K Harmon; C R Stockard; A S Petersen; J M Markert; G Y Gillespie; W E Grizzle; D J Buchsbaum; S A Kaliberov
Journal:  Cancer Gene Ther       Date:  2009-04-10       Impact factor: 5.987

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.